Document Detail


Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy.
MedLine Citation:
PMID:  22180711     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To investigate the effectiveness of low-volume plus ascorbic acid [polyethylene glycol plus ascorbic acid (PEG + Asc)] and high-volume plus simethicone [polyethylene glycol plus simethicone (PEG + Sim)] bowel preparations.
METHODS: A total of one hundred and forty-four outpatients (76 males), aged from 20 to 84 years (median age 59.5 years), who attended our Department, were divided into two groups, age and sex matched, and underwent colonoscopy. Two questionnaires, one for patients reporting acceptability and the other for endoscopists evaluating bowel cleansing effectiveness according to validated scales, were completed. Indications, timing of examination and endoscopical findings were recorded. Biopsy forceps were used as a measuring tool in order to determine polyp endoscopic size estimation. Difficulty in completing the preparation was rated in a 5-point Likert scale (1 = easy to 5 = unable). Adverse experiences (fullness, cramps, nausea, vomiting, abdominal pain, headache and insomnia), number of evacuations and types of activities performed during preparation (walking or resting in bed) were also investigated.
RESULTS: Seventy-two patients were selected for each group. The two groups were age and sex matched as well as being comparable in terms of medical history and drug therapies taken. Fourteen patients dropped out from the trial because they did not complete the preparation procedure. Ratings of global bowel cleansing examinations were considered to be adequate in 91% of PEG + Asc and 88% of PEG + Sim patients. Residual Stool Score indicated similar levels of amount and consistency of residual stool; there was a significant difference in the percentage of bowel wall visualization in favour of PEG + Sim patients. In the PEG + Sim group, 12 adenomas ≤ 10 mm diameter (5/left colon + 7/right colon) vs 9 (8/left colon + 1/right colon) in the PEG + Asc group were diagnosed. Visualization of small lesions seems to be one of the primary advantages of the PEG + Sim preparation.
CONCLUSION: PEG + Asc is a good alternative solution as a bowel preparation but more improvements are necessary in order to achieve the target of a perfect preparation.
Authors:
Stefano Pontone; Rita Angelini; Monica Standoli; Gregorio Patrizi; Franco Culasso; Paolo Pontone; Adriano Redler
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  17     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-12-19     Completed Date:  2012-02-13     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  4689-95     Citation Subset:  IM    
Affiliation:
Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Roma, Italy. stefano.pontone@uniroma1.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antioxidants / therapeutic use
Ascorbic Acid / therapeutic use*
Cathartics / therapeutic use*
Colonoscopy / methods*
Colorectal Neoplasms / diagnosis
Emollients / therapeutic use
Humans
Male
Middle Aged
Pharmaceutical Solutions / chemistry,  therapeutic use
Polyethylene Glycols / therapeutic use
Questionnaires
Simethicone / therapeutic use*
Therapeutic Irrigation / methods*
Young Adult
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Cathartics; 0/Emollients; 0/Pharmaceutical Solutions; 0/Polyethylene Glycols; 50-81-7/Ascorbic Acid; 8050-81-5/Simethicone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.
Next Document:  Optimizing management of pancreaticopleural fistulas.